CytoSorbents

CytoSorbents(CTSO)

PRINCETON, NJ
Biotechnology
WebsiteLinkedInCareers Page

Focus: Blood Purification Therapy

CytoSorbents is a life sciences company focused on Blood Purification Therapy.

GastroenterologyInfectious DiseasesCardiovascular
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT05259514CytoSorb SAH Trial
N/A
CytoSorb-Therapy
Septic Shock
N/A
Clinical Trials (1)
NCT04013269Adjuvant Therapy With CytoSorb in Refractory Septic Shock
N/A
N/A
Clinical Trials (1)
NCT05077124Safe and Timely Antithrombotic Removal (STAR) Registry
N/A
hemoadsorber for removal of cytokines
Infective Endocarditis
N/A
Clinical Trials (1)
NCT03266302Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis
N/A
Cytokine Adsorption
Septic Shock
N/A
Clinical Trials (1)
NCT04910893Cytokine Adsorption in Severe, Refractory Septic Shock
N/A
CytoSorb 300 mL device
Emergent Cardiothoracic Surgery
N/A
Clinical Trials (1)
NCT04131959Ticagrelor CytoSorb Hemoadsorption
N/A
Cytosorb® 300 ml
Septic Shock
N/A
Clinical Trials (1)
NCT04963920A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
N/A
CytoSorb® treatment
Acute on Chronic Liver Failure
N/A
Clinical Trials (1)
NCT05131230CytoSorb® in Patients With Acute on Chronic Liver Failure
N/A
CytoSorb 300 mL device
COVID-19
N/A
Clinical Trials (1)
NCT04391920Registry of CytoSorb Therapy in COVID-19 ICU Patients
N/A
CytoSorb
Septic Shock
N/A
Clinical Trials (1)
NCT05146336CytOSorb TreatMent Of Critically Ill PatientS Registry
N/A
N/A
Clinical Trials (1)
NCT03945708Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?
N/A
Hemoadsorption
Cardiac Arrest
N/A
Clinical Trials (1)
NCT03632837HaemoAdsorption Nach Reanimation An ECMO
N/A
N/A
Clinical Trials (1)
NCT06079021COOLEY- Study: ACute on ChrOnic Liver FailurE Using the CYtosorb Device
N/A
N/A
Clinical Trials (1)
NCT04048434Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)
N/A
Blood sampling and analysis
Acute Coronary Syndrome
N/A
Clinical Trials (1)
NCT04625764Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery
N/A
N/A
Clinical Trials (1)
NCT02566525CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
N/A
CytoSorb 300 mL device
Heart Failure
N/A
Clinical Trials (1)
NCT04596813Role of Cytosorb in Left Ventricular Assist Device Implantation
N/A
CytoSorb cytokine elimination
Inflammation
N/A
Clinical Trials (1)
NCT02606799Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy
N/A
Sham comparator
Hemorrhage, Surgical
N/A
Clinical Trials (1)
NCT05093504Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
N/A
N/A
Clinical Trials (1)
NCT03104179Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB
N/A
N/A
Clinical Trials (1)
NCT03384875CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
N/A
DrugSorb-ATR system
Hemorrhage, Surgical
N/A
Clinical Trials (1)
NCT04976530Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
N/A
CytoSorb Device
Rhabdomyolysis
Phase 2
Clinical Trials (1)
NCT02111018Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
Phase 2
Phase 3
Clinical Trials (1)
NCT01879176Cytokine Removal in Cardiopulmonary Bypass Patients
Phase 3
CytoSorb hemoperfusion
Sepsis
Phase 3
Clinical Trials (1)
NCT04643639Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
Phase 3
Phase 4
Clinical Trials (1)
NCT03082469Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 26 clinical trials
SEC Filings: 2 available

Financials (FY2024)

Revenue
$31M193%
Net Income
-$29M
Cash
$14M
Source: SEC 10-K Filing

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles